676
Views
0
CrossRef citations to date
0
Altmetric
Basic Sciences Investigations

The relationship between thiamin, folic acid and cognitive function in a rat model of uremia

, , , , , , , , & show all
Article: 2329257 | Received 13 Jun 2023, Accepted 06 Mar 2024, Published online: 14 Mar 2024

References

  • Viggiano D, Wagner CA, Martino G, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020;16(8):1–10. doi:10.1038/s41581-020-0266-9.
  • Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74(6):782–790. doi:10.1053/j.ajkd.2019.05.017.
  • Lu R, Xu C, Li Y, et al. The incidence prognosis and risk factors of cognitive impairment in maintenance haemodialysis patients. Blood Purif. 2019;47(1-3):101–108. doi:10.1159/000493524.
  • Kalirao P, Pederson S, Foley RN, et al. Cognitive impairment in peritoneal dialysis patients. Am J Kidney Dis. 2011;57(4):612–620. doi:10.1053/j.ajkd.2010.11.026.
  • Jabbari B, Vaziri ND. The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial Int. 2018;22(2):150–160. doi:10.1111/hdi.12587.
  • Hamed SA. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Expert Rev Clin Pharmacol. 2019;12(1):61–90. doi:10.1080/17512433.2019.1555468.
  • Stanhewicz AE, Kenney WL. Role of folic acid in nitric oxide bioavailability and vascular endothelial function. Nutr Rev. 2017;75(1):61–70. doi:10.1093/nutrit/nuw053.
  • Angelini A, Cappuccilli ML, Magnoni G, et al. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. G Ital Nefrol. 2021;38(4):2021-vol4.
  • Koohpeyma H, Goudarzi I, Elahdadi Salmani M, et al. Postnatal administration of homocysteine induces cerebellar damage in rats: protective effect of folic acid. Neurotox Res. 2019;35(3):724–738. doi:10.1007/s12640-018-9979-y.
  • Zareie M, De Vriese AS, Hekking LHP, et al. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol Dial Transplant. 2005;20(7):1350–1361. doi:10.1093/ndt/gfh835.
  • Platt R, Roscoe MH, Smith FW. Experimental renal failure. Clin Sci. 1952;11(3):217–231.
  • Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858. doi:10.1038/nprot.2006.116.
  • Chuang YC, Yang JL, Yang DI, et al. Roles of Sestrin2 and ribosomal protein S6 in transient global Ischemia-Induced hippocampal neuronal injury. Int J Mol Sci. 2015;16(11):26406–26416. doi:10.3390/ijms161125963.
  • Braun M, Kirsten R, Rupp NJ, et al. Quantification of protein expression in cells and cellular subcompartments on immunohistochemical sections using a computer supported image analysis system. Histol Histopathol. 2013;28(5):605–610. doi:10.14670/HH-28.605.
  • Othman MZ, Hassan Z, Che Has AT. Morris water maze: a versatile and pertinent tool for assessing spatial learning and memory. Exp Anim. 2022;71(3):264–280. doi:10.1538/expanim.21-0120.
  • Lissner LJ, Wartchow KM, Toniazzo AP, et al. Object recognition and morris water maze to detect cognitive impairment from mild hippocampal damage in rats: a reflection based on the literature and experience. Pharmacol Biochem Behav. 2021;210:173273. doi:10.1016/j.pbb.2021.173273.
  • Fujisaki K, Tsuruya K, Yamato M, et al. Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: neuroprotective effect of tempol. Nephrol Dial Transplant. 2014;29(3):529–538. doi:10.1093/ndt/gft327.
  • Massy ZA, Ceballos I, Chadefaux-Vekemens B, et al. HomocystIine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl. 2001;78: s 243–245. doi:10.1046/j.1523-1755.2001.59780243.x.
  • Gioda CR, de Oliveira Barreto T, Prímola-Gomes TN, et al. Cardiac oxidative stress is involved in heart failure induced by thiamine deprivation in rats. Am J Physiol Heart Circ Physiol. 2010;298(6):H2039–2045. doi:10.1152/ajpheart.00820.2009.
  • Jamison RL, Hartigan P, Kaufman JS, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298(10):1163–1170. doi:10.1001/jama.298.10.1163.
  • Brady CB, Gaziano JM, Cxypoliski RA, et al. Homocysteine lowering and cognition in CKD: the veterans affairs homocysteine study. Am J Kidney Dis. 2009;54(3):440–449. doi:10.1053/j.ajkd.2009.05.013.
  • Chen H, Liu S, Ge B, et al. Effects of folic acid and vitamin B12 supplementation on cognitive impairment and inflammation in patients with Alzheimer’s disease: a randomized, Single-Blinded, Placebo-Controlled trial. J Prev Alzheimers Dis. 2021;8(3):249–256. doi:10.14283/jpad.2021.22.
  • Jiang X, Guo Y, Cui L, et al. Study of diet habits and cognitive function in thineseese Middle-Aged and elderly population: the association between folic acid, B vitamins, vitamin D, coenzyme Q10 supplementation and cognitive ability. Nutrients. 2023;15(5):1243. doi:10.3390/nu15051243.
  • Capelli I, Cianciolo G, Gasperoni L, et al. Folic acid and vitamin B12 administration in CKD, why not? Nutrients. 2019;11(2):383. doi:10.3390/nu11020383.